S. Typhimurium
Showing 1 - 25 of 6,749
Trivalent Salmonella Conjugate Vaccine (TSCV) Trial (TSCV (Full-strength), TSCV (Half-strength), Typbar-TCV)
Not yet recruiting
- Trivalent Salmonella Conjugate Vaccine (TSCV)
- TSCV (Full-strength)
- +3 more
- (no location specified)
Mar 24, 2023
Risk Reduction Trial in Baltimore (Trivalent Invasive Salmonella Disease Vaccine (6.25 µg), Trivalent Invasive Salmonella
Completed
- Risk Reduction
- Trivalent Invasive Salmonella Disease Vaccine (6.25 µg)
- +4 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
Oct 25, 2021
Salmonella Infections, Salmonella Typhimurium, Non-typhoidal Salmonella (NTS) Trial in London (Salmonella Typhimurium)
Not yet recruiting
- Salmonella Infections
- +7 more
- Salmonella Typhimurium
-
London, England, United KingdomImperial College London
May 11, 2023
Metastatic Pancreatic Cancer Trial in Montreal (Salmonella-IL2, FOLFIRINOX Alone (Historical Controls), Gemcitabine/Abraxane
Recruiting
- Metastatic Pancreatic Cancer
- Salmonella-IL2
- +2 more
-
Montreal, Quebec, CanadaSegal Cancer Centre/ Mortimer B. Davis-Jewish General Hosptial
May 3, 2022
Salmonella Infections Trial (biological, combination product, drug, other)
Not yet recruiting
- Salmonella Infections
- Invasive nontyphoidal Salmonella-typhoid conjugate vaccine (iNTS-TCV) low dose
- +10 more
- (no location specified)
Jul 27, 2022
Salmonella Typhi Infection Trial in Oxford (Salmonella Typhi challenge)
Completed
- Salmonella Typhi Infection
- Salmonella Typhi challenge
-
Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology and Tropical Medicine (CCVTM)
Feb 8, 2022
Pre-diabetes Trial in London (Normal Healthy Diet, Seaweed Group, Placebo Diet Group)
Recruiting
- Pre-diabetes
- Normal Healthy Diet
- +2 more
-
London, UK, United KingdomHealth Sciences Research Centre, Life Sciences Department, Unive
Nov 26, 2023
Neonatal Sepsis Trial in Milano (Preterm Infants - fed fermented formula, Preterm Infants - fed standard formula, Pre-term
Recruiting
- Neonatal Sepsis
- Preterm Infants - fed fermented formula
- +2 more
-
Milano, ItalyUnità di Neonatologia e Terapia Intensiva Neonatale, Clinica Ma
Jun 1, 2022
Schistosoma Related Bladder Diseases.
Not yet recruiting
- Schistosoma Haematobium
- Immunohistochemistry staining,
- microscopic examination of urine
-
Assiut, EgyptAssiut University Hospital
Jul 4, 2023
Obesity, Healthy Volunteers Trial in Dallas (S309309, Itraconazole)
Recruiting
- Obesity
- Healthy Volunteers
-
Dallas, TexasFortrea Clinical Research Unit Inc.
Oct 30, 2023
Myeloproliferative Disorders, Essential Thrombocythemia, Tumors Trial (JNJ-88549968)
Not yet recruiting
- Myeloproliferative Disorders
- +3 more
- (no location specified)
Nov 21, 2023
2WIN-S Portable Refractor Trial in Bangkok (2WIN-S portable refractor)
Active, not recruiting
- 2WIN-S Portable Refractor
- 2WIN-S portable refractor
-
Bangkok, ThailandRajavithi Hospital
Nov 20, 2023
Locally Advanced Gastric Adenocarcinoma, Chemo Effect Trial in Hanzhou (Docetaxel, Tegafur-Gimeracil-Oteracil)
Recruiting
- Locally Advanced Gastric Adenocarcinoma
- Chemotherapy Effect
-
Hanzhou, Zhejiang, ChinaGastrointestinal Department of Second Affiliated Hospital of Zhe
Apr 2, 2023
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-75348780)
Recruiting
- Lymphoma, Non-Hodgkin
- Leukemia, Lymphocytic, Chronic, B-Cell
-
Birmingham, Alabama
- +43 more
Jan 27, 2023
Diagnostic Value of Serum Cathepsin S and Chromogranin A in DKD
Not yet recruiting
- Diabetic Kidney Disease
- cathepsin S and chromogranin A
- (no location specified)
Oct 5, 2023
Serplulimab,Gastric Cancer, Adjuvant Therapy Trial in Shanghai (Serplulimab, Docetaxel, S1)
Recruiting
- Serplulimab,Gastric Cancer, Adjuvant Therapy
- Serplulimab
- +2 more
-
Shanghai, ChinaZhang Zizhen
Mar 3, 2023
Hypervirulent and Multi-drug Resistant Pathogens
Recruiting
- Multiresistant Bacterial Pathogens
- Virulent Bacterial Pathogens
- Analysis of Bacterial Genome
-
Basel, Switzerland
- +4 more
Dec 15, 2021
Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial in Worldwide (JNJ-64264681)
Recruiting
- Lymphoma, Non-Hodgkin
- Leukemia, Lymphocytic, Chronic, B-Cell
-
New York, New York
- +15 more
Jan 27, 2023
Multiple Sclerosis Trial in Knoxville (Tolebrutinib, Placebo)
Completed
- Multiple Sclerosis
- Tolebrutinib
- Placebo
-
Knoxville, TennesseeNew Orleans Clinical Research Site Number : 8400001
Oct 24, 2023
Relapsed or Refractory Multiple Myeloma Trial in Worldwide (JNJ-79635322)
Recruiting
- Relapsed or Refractory Multiple Myeloma
-
Edegem, Belgium
- +16 more
Jan 27, 2023
Non-carious Cervical Lesions Trial in Santiago (Evaporation time for 5 seconds, Evaporation time for 25 seconds,
Completed
- Non-carious Cervical Lesions
- Evaporation time for 5 seconds
- +3 more
-
Santiago, Región Metropolitana, ChileMario Felipe Gutiérrez Reyes
Jul 11, 2023
Postprandial Lipemia, Postprandial Glycemia, Gastric Emptying Trial in Kajang (HGI+palm olein, LGI+palm olein, HGI+soy bean oil)
Recruiting
- Postprandial Lipemia
- +2 more
- HGI+palm olein
- +3 more
-
Kajang, Selangor, MalaysiaMalaysian Palm Oil Board
Jul 28, 2023